Literature DB >> 27567914

Superficial wound infection does not cause inferior clinical outcome after TKA.

Pau Guirro1, Pedro Hinarejos2, Lluís Puig-Verdie2, Juan Sánchez-Soler2, Joan Leal-Blanquet2, Raul Torres-Claramunt2, Joan-Carles Monllau2.   

Abstract

PURPOSE: Superficial wound infections do not lead to chronic prosthetic joint infection. Therefore, it has been hypothesized that a superficial infection of a surgical wound following a successfully treated TKA does not lead to a lower functional outcome at long-term follow-up. This may be due to early diagnosis and proper treatment without interrupting the rehabilitation programme. The purpose of this study was to support the hypothesis by comparing the functional outcome and health-related quality of life (HRQoL) of superficial infections treated successfully after primary total knee arthroplasty (TKA).
METHODS: In a 3000 prospective TKA cohort, 45 superficial infections were compared to a control group of 629 TKA without complications. The functional outcome, health quality, expectations and revision rate were compared between the study and control groups.
RESULTS: The groups were comparable in terms of demographic values and preoperative scores. The mean follow-up was 74.57 months (SD ± 7.1). No statistical differences were observed relative to functional outcomes at the final follow-up as measured with the Knee Society Score (156.9 vs 168.4; n.s) and range of motion (0.2-114.4 vs 0.7-112.3; n.s). For the HRQoL, no differences in the physical (40.0 vs 40.6; n.s) and mental (43.2 vs 45.8; n.s) SF-36 scores were found. Neither were there differences in post-operative expectations and the revision rate.
CONCLUSIONS: In a long-term follow-up, a different clinical outcome and HRQoL were not obtained after a successfully treated superficial infection following a TKA when compared to a TKA without complications. Based on the findings of the study, additional complications are not anticipated after a successfully treated superficial wound infection in TKA. Therefore, a different follow-up to that of a non-complicated TKA is not recommended when the early post-operative superficial wound infection has been appropriately treated. A superficial infection successfully treated in the acute post-operative period should be considered solved at long-term follow-up. LEVEL OF EVIDENCE: Therapeutic study, Level III.

Entities:  

Keywords:  Clinical outcome; Functional outcome; Health-related quality of life; Superficial wound infection; Total knee arthroplasty

Mesh:

Substances:

Year:  2016        PMID: 27567914     DOI: 10.1007/s00167-016-4290-z

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  34 in total

1.  Total knee replacement. Postacute phase in rehabilitation: objectives and strategies in postacute treatment.

Authors:  Carola Cademartiri; Giovanni Soncini
Journal:  Acta Biomed       Date:  2004-04

2.  [Population reference values of the Spanish version of the Health Questionnaire SF-36].

Authors:  J Alonso; E Regidor; G Barrio; L Prieto; C Rodríguez; L de la Fuente
Journal:  Med Clin (Barc)       Date:  1998-10-10       Impact factor: 1.725

3.  Survivorship of cemented total knee arthroplasty.

Authors:  D E Font-Rodriguez; G R Scuderi; J N Insall
Journal:  Clin Orthop Relat Res       Date:  1997-12       Impact factor: 4.176

4.  Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection.

Authors:  Atul F Kamath; Kevin L Ong; Edmund Lau; Vanessa Chan; Thomas P Vail; Harry E Rubash; Daniel J Berry; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2015-03-31       Impact factor: 4.757

5.  Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS).

Authors:  Kyoung-Ho Song; Eu Suk Kim; Young Keun Kim; Hye Young Jin; Sun Young Jeong; Yee Gyung Kwak; Yong Kyun Cho; Joohon Sung; Yeong-Seon Lee; Hee-Bok Oh; Tae Kyun Kim; Kyung-Hoi Koo; Eui-Chong Kim; June Myung Kim; Tae Yeol Choi; Hyo Youl Kim; Hee Jung Choi; Hong Bin Kim
Journal:  Infect Control Hosp Epidemiol       Date:  2012-09-24       Impact factor: 3.254

6.  Translation and validation of 'The Knee Society Clinical Rating System' into Spanish.

Authors:  Oscar Ares; Enric Castellet; Francisco Maculé; Vicenç León; Elvira Montañez; Alicia Freire; Pedro Hinarejos; Ferran Montserrat; Juan Ramon Amillo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-25       Impact factor: 4.342

Review 7.  Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials.

Authors:  Catherine J Minns Lowe; Karen L Barker; Michael Dewey; Catherine M Sackley
Journal:  BMJ       Date:  2007-09-20

8.  Surgical treatment of early wound complications following primary total knee arthroplasty.

Authors:  Daniel D Galat; Scott C McGovern; Dirk R Larson; Jeffrey R Harrington; Arlen D Hanssen; Henry D Clarke
Journal:  J Bone Joint Surg Am       Date:  2009-01       Impact factor: 5.284

9.  Early return to surgery for evacuation of a postoperative hematoma after primary total knee arthroplasty.

Authors:  Daniel D Galat; Scott C McGovern; Arlen D Hanssen; Dirk R Larson; Jeffrey R Harrington; Henry D Clarke
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

10.  Long term follow-up of successfully treated superficial wound infections following TKA.

Authors:  Pau Guirro; Pedro Hinarejos; Xavier Pelfort; Joan Leal-Blanquet; Raul Torres-Claramunt; Lluís Puig-Verdie
Journal:  J Arthroplasty       Date:  2014-09-06       Impact factor: 4.757

View more
  1 in total

1.  Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran.

Authors:  Mohammad Naghi Tahmasebi; Arash Sharafat Vaziri; Fardis Vosoughi; Mohamad Tahami; Majid Khalilizad; Hamid Rabie
Journal:  J Orthop Surg Res       Date:  2021-03-17       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.